This hypothesis proposes that proteinopathic processes spread through the brain in a 'prion-like' manner, wherein misfolded proteins can propagate their abnormal conformation to neighboring proteins, leading to the progressive spread of pathological aggregates across neural circuits.
Type: Mechanistic Proposal
Confidence: Supported by substantial evidence
Related Diseases: Alzheimer disease, Parkinson disease, Lewy body disease, FTLD, Amyotrophic Lateral Sclerosis (ALS), Huntington's disease
The prion-like propagation hypothesis suggests that misfolded proteins can act as template molecules that induce conformational changes in native proteins of the same type. This process involves:
- Pathological proteins undergo misfolding due to genetic mutations, oxidative stress, or age-related proteostasis decline
- These misfolded proteins aggregate into oligomers and fibrils
- Soluble aggregates serve as seeds for further propagation
- Misfolded proteins can be released into the extracellular space
- They enter neighboring neurons via endocytosis or membrane pores
- Exosome-mediated transfer facilitates spread between cells
- Tunneling nanotubes provide direct cytoplasmic connections
- Internalized seeds recruit and convert native proteins to the misfolded form
- This amplification process leads to exponential accumulation of aggregates
- The newly formed aggregates become seeds for further propagation
- Cell-to-cell transfer: In vitro studies show α-synuclein, tau, and Aβ aggregates transfer between neurons
- Animal models: Injecting preformed aggregates into brains induces widespread pathology
- Strain-specific propagation: Different protein conformations (strains) maintain distinct pathological features
- Braak staging: Tau pathology spreads in a predictable pattern from entorhinal cortex
- Lewy body progression: α-synuclein pathology follows brainstem-to-cortical trajectory
- Pattern analysis: Aggregate distribution correlates with connected neural networks
- CSF biomarkers: Levels of aggregate-related proteins reflect disease progression
- PET imaging: Radioligands detect aggregate deposition in living patients
- Blood markers: Peripheral measurements correlate with CNS pathology
- Nucleation-dependent polymerization: Slow lag phase followed by rapid extension
- Secondary nucleation: Existing aggregates catalyze new seed formation
- Fragmentation: Larger aggregates break into smaller, more infectious pieces
- Autophagy: Macroautophagy and chaperone-mediated autophagy target aggregates
- Proteasomal degradation: Ubiquitin-proteasome system clears misfolded proteins
- Extracellular clearance: Microglia and astrocyte uptake
- Aggregate inhibitors: Small molecules that prevent misfolding
- Antibody therapies: Passive immunization against pathological proteins
- Seed neutralization: Agents that destabilize existing aggregates
- Autophagy enhancers: mTOR inhibitors, rapamycin analogs
- Gene therapy: Expression of aggregation-preventing proteins
- Cell replacement: Stem cell approaches to replace affected neurons
This hypothesis is strongly supported by multiple lines of evidence from experimental models, human pathology studies, and biomarker research. The prion-like propagation model has become a central framework for understanding disease progression in neurodegenerative disorders.
- Prion-like mechanisms in neurodegenerative diseases (Nature Reviews Neuroscience, 2020)
- Evidence for prion-like mechanisms in Alzheimer's disease (Acta Neuropathologica, 2019)
- Propagation of α-synuclein pathology (Neuron, 2019)
- Tau oligomers and prion-like propagation (Molecular Neurobiology, 2018)
- Cell-to-cell transmission of misfolded proteins (Cell, 2017)
- Strain diversity in neurodegenerative disease aggregates (Nature, 2018)
- Exosome-mediated propagation of protein aggregates (Nature Neuroscience, 2018)
- Braak hypothesis and staging of tau pathology (Acta Neuropathologica, 2020)